Endologix, Inc. is singularly focused on providing innovative, minimally invasive technologies for aortic disorders. The Company's product offering includes a variety of endovascular stent grafts for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. Designed around key issues with challenging anatomies, difficult access, and aneurysm sealing, Endologix products have been clinically proven in delivering positive patient outcomes.
Gross profit (Q2, 2019)
Gross profit margin (Q2, 2019), %
Net income (Q2, 2019)
EBIT (Q2, 2019)
Market capitalization (11-Oct-2019)
Closing stock price (11-Oct-2019)
|USD||Q1, 2017||Q2, 2017||Q3, 2017||Q1, 2018||Q2, 2018||Q3, 2018||Q1, 2019||Q2, 2019|
Depreciation and Amortization
Endologix has 468 Twitter Followers. The number of followers has increased 1.3% month over month and increased 4.8% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Endologix founded?
Endologix was founded in 1992.
Who are Endologix key executives?
Endologix's key executives are John Onopchenko, Vaseem Mahboob and Michael Chobotov.
How many employees does Endologix have?
Endologix has 528 employees.
What is Endologix revenue?
Latest Endologix annual revenue is $156.5 m.
What is Endologix revenue per employee?
Latest Endologix revenue per employee is $296.4 k.
Who are Endologix competitors?
Competitors of Endologix include U.S. Stem Cell, Cannabis Sativa and Vital Therapies.
Where is Endologix headquarters?
Endologix headquarters is located at 2 Musick, Irvine.
Where are Endologix offices?
Endologix has offices in Irvine and Rosmalen.
How many offices does Endologix have?
Endologix has 2 offices.
Receive alerts for 300+ data fields across thousands of companies